Octopus BiosafetyXPAR:MLOCT -2.70%10 WACC % is 8.38% as of Jul. 04, 2026, which is 151% above its 10-year median of 3.34. GuruFocus rates XPAR:MLOCT with a GF Score™ of 10/100 and a GF Value™ of €0.08 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 2,515 Hardware companies, Octopus Biosafety ranks worse than 51.09% on this metric.
As of today (2026-07-04), Octopus Biosafety's weighted average cost of capital is 8.38%%. Octopus Biosafety's ROIC % is -80.62% (calculated using TTM income statement data).
Octopus Biosafety earns returns that do not match up to its cost of capital. It will destroy value as it grows.
For a comprehensive WACC calculation, please access the WACC Calculator.
Octopus Biosafety (XPAR:MLOCT) WACC % Explanation
Because it costs money to raise capital. A firm that generates higher ROIC % than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.
As of today, Octopus Biosafety's weighted average cost of capital is 8.38%%. Octopus Biosafety's ROIC % is -80.62% (calculated using TTM income statement data).
Octopus Biosafety earns returns that do not match up to its cost of capital. It will destroy value as it grows.
Be Aware
1. GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding latest one-year annual average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together.
For companies that report quarterly, GuruFocus combines all of the most recent year's quarterly debt data from the beginning of the year to the year-end and calculates the average.
For companies that report semi-annually, GuruFocus combines all of the most recent year's semi-annual debt data from the start of the year to the year-end and calculates the average.
For companies that report annually, GuruFocus combines the beginning and ending annual debt data from the most recent year and then calculates the average.
2. The WACC formula discussed above does not include Preferred Stock. Please adjust if preferred stock is considered.
3. (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.
4. GuruFocus uses the latest annual Interest Expense divided by the latest one-year annual average debt to get the simplified cost of debt.
Related Terms
Octopus Biosafety WACC % Historical Data
* Premium members only.
The historical data trend for Octopus Biosafety's WACC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Computer Hardware subindustry, Octopus Biosafety's WACC %, along with its competitors' market caps and WACC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Octopus Biosafety WACC % vs Hardware Industry
For the Hardware industry and Technology sector, Octopus Biosafety's WACC % distribution charts can be found below:
* The bar in red indicates where Octopus Biosafety's WACC % falls into.
The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. The WACC is commonly referred to as the firm's cost of capital. Generally speaking, a company's assets are financed by debt and equity. WACC is the average of the costs of these sources of financing, each of which is weighted by its respective use in the given situation. By taking a weighted average, we can see how much interest the company has to pay for every dollar it finances.
WACC
=
E
/
(E + D)
*
Cost of Equity
+
D
/
(E + D)
*
Cost of Debt
*
(1 - Tax Rate)
1. Weights:
Generally speaking, a company's assets are financed by debt and equity. We need to calculate the weight of equity and the weight of debt.
The market value of equity (E) is also called "Market Cap". As of today, Octopus Biosafety's market capitalization (E) is €22.883 Mil.
The market value of debt is typically difficult to calculate, therefore, GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding the latest one-year annual average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together. As of Dec. 2024, Octopus Biosafety's latest one-year annual average Book Value of Debt (D) is €0.45 Mil.
a) weight of equity = E / (E + D) = 22.883 / (22.883 + 0.45) = 0.9807
b) weight of debt = D / (E + D) = 0.45 / (22.883 + 0.45) = 0.0193
2. Cost of Equity:
GuruFocus uses Capital Asset Pricing Model (CAPM) to calculate the required rate of return. The formula is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
a) GuruFocus uses 10-Year Treasury Constant Maturity Rate as the risk-free rate. It is updated daily. The current risk-free rate is 3.7416%. Please go to Economic Indicators page for more information. Please note that we use the 10-Year Treasury Constant Maturity Rate of the country/region where the company is headquartered. If the data for that country/region is not available, then we will use the 10-Year Treasury Constant Maturity Rate of the United States as default.
b) Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. Octopus Biosafety's beta is 0.8001.
c) (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.
Cost of Equity = 3.7416% + 0.8001 * 6% = 8.5422%
3. Cost of Debt:
GuruFocus uses latest annual Interest Expense divided by the latest one-year annual average debt to get the simplified cost of debt.
As of Dec. 2024, Octopus Biosafety's interest expense (positive number) was €0.001 Mil. Its total Book Value of Debt (D) is €0.45 Mil.
Cost of Debt = 0.001 / 0.45 = 0.2222%.
4. Multiply by one minus annual Tax Rate:
GuruFocus uses the most recent annual Tax Expense divided by the most recent annual Pre-Tax Income to calculate the tax rate. The calculated annual tax rate is limited to between 0% and 100%. If the calculated tax rate is higher than 100%, it is set to 100%. If the calculated tax rate is less than 0%, it is set to 0%.
The latest calculated annual Tax Rate = -0.209 / -0.839 = 24.91%.
Octopus Biosafety's Weighted Average Cost Of Capital (WACC) for Today is calculated as:
WACC
=
E / (E + D)
*
Cost of Equity
+
D / (E + D)
*
Cost of Debt
*
(1 - Tax Rate)
=
0.9807
*
8.5422%
+
0.0193
*
0.2222%
*
(1 - 24.91%)
=
8.38%
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Octopus Biosafety (XPAR:MLOCT) has a WACC % of 8.38% as of Jul. 04, 2026. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on Octopus Biosafety and its competitors. This is 151% above median its historical median of 3.34. Over the past decade, Octopus Biosafety's WACC % has ranged from 0.78 to 9.93. According to the industry distribution chart, Octopus Biosafety ranks #1285 out of 2515 companies in the Hardware industry, placing it in the top 51.1%.
Is Octopus Biosafety's WACC % too high?
Octopus Biosafety's current WACC % of 8.38% is 151% above median its 10-year median of 3.34. Over the past 10 years, this metric has ranged from a low of 0.78 to a high of 9.93. The Hardware industry median WACC % is 8.16. Octopus Biosafety's value of 8.38% is 2.7% above this industry median. Based on the distribution chart, Octopus Biosafety ranks #1285 out of 2515 companies in the Hardware industry, which is below the industry midpoint. Overall, Octopus Biosafety has a GF Score™ of 10/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's WACC % compare to SNDK and DELL?
According to the Hardware industry distribution chart, Octopus Biosafety ranks #1285 out of 2515 companies for WACC %. This places Octopus Biosafety in the lower half of its industry. The industry median WACC % is 8.16. Octopus Biosafety's value of 8.38% is 2.7% above this benchmark. Historically, Octopus Biosafety's own WACC % has ranged from 0.78 to 9.93 over the past decade. While the company's 10-year median is 3.34 vs. the industry median of 8.16, Octopus Biosafety has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good WACC % for a Hardware company?
The median WACC % among Hardware companies is 8.16, based on 2,515 companies in the industry. Companies in the top quartile (top 25%) have a WACC % significantly above this median, while those in the bottom quartile fall well below. However, WACC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Octopus Biosafety's current WACC % of 8.38% is 2.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high WACC % mean?
A high WACC % can signal that a stock is expensive relative to its fundamentals. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on Octopus Biosafety and its competitors. For the Hardware industry, the median WACC % is 8.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Octopus Biosafety's current WACC % is 8.38%, which is 151% above median its own 10-year median of 3.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Based on GuruFocus' analysis, Octopus Biosafety (XPAR:MLOCT) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.08, compared to a current price of €0.18 — trading 125% above its estimated fair value. The current WACC % is 8.38%, which is 151% above median its 10-year median of 3.34 and 2.7% above the Hardware industry median of 8.16. Octopus Biosafety's overall GF Score™ is 10/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is WACC % calculated?
WACC % is calculated from a company's financial statements. For Octopus Biosafety (XPAR:MLOCT), the current WACC % is 8.38% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Octopus Biosafety (XPAR:MLOCT) Overvalued in 2026?
Based on GuruFocus' analysis, Octopus Biosafety stock appears to be overvalued.
The current stock price of €0.18 is trading 125% above its estimated GF Value™ of €0.08.
GuruFocus considers Octopus Biosafety to be Significantly Overvalued.
Key valuation signals for XPAR:MLOCT:
WACC %: 8.38% (151% above median its 10-year median of 3.34)
GF Value™: €0.08 vs. price of €0.18 (125% above fair value)
Industry Position: 2.7% above the Hardware median (#1285 of 2515)
No single metric tells the full story. See the XPAR:MLOCT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
10GF Score
Get the complete analysis for XPAR:MLOCT
WACC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLOCT has been successfully added to your 
